# HyperSpectral

> HyperSpectral is an Alexandria, Virginia software company building CortX, a hardware-agnostic spectral foundation model designed to turn readings from spectroscopy instruments into rapid identifications of pathogens, contaminants, materials and process conditions. Its wager is that the valuable layer is not another proprietary camera, but a reusable intelligence platform that can sit over existing sensors and serve clinical diagnostics, biomanufacturing, food supply chains, defense and industrial quality control.

- **Founded:** 2022
- **Headquarters:** Alexandria, United States
- **Founders:** Matt Theurer (Co-Founder, President & CEO), Lauren Stack (Co-Founder & COO), Vince Lubsey (Co-Founder & CTO)
- **Team size:** Approximately 31 employees listed on LinkedIn in August 2026; public company size band is 11-50.
- **Products:** SpecAI platform, CortX, SFM Release 001, Pre-built industry solutions, Partner programs
- **Notable:** Emerged from stealth with an $8.5 million Series A in June 2024., Advanced its DARPA cooperative agreement to Phase 2 in December 2024., Won the 2025 SPIE Prism Award for software.

## Products & services

- **SpecAI platform** — The company's original branded software platform for combining spectroscopy, proprietary datasets and AI to identify spectral signatures and support rapid detection workflows.
- **CortX** — A spectral foundation model and molecular perception layer designed to infer identity, composition and state from readings across spectroscopy modalities and third-party instruments.
- **SFM Release 001** — A pre-release beta that accepts mass-spectrometry files and returns ranked identifications with confidence scores; access is offered to qualified researchers and institutions.
- **Pre-built industry solutions** — Domain-specific integrations for clinical diagnostics, biomanufacturing, food and supply chains, defense and security, and industrial quality control.
- **Partner programs** — Research, device-manufacturer, data and action-partner programs that expand training data, sensor compatibility and deployment pathways.

## Achievements

- Emerged from stealth with an $8.5 million Series A in June 2024.
- Advanced its DARPA cooperative agreement to Phase 2 in December 2024.
- Won the 2025 SPIE Prism Award for software.
- Named in Gartner research on emerging computer-vision technology innovators in 2025.
- Named a 2025 R&D 100 finalist for the SpecAI platform.
- Received Frost & Sullivan's 2025 North American Technology Innovation Leadership recognition for AI-powered spectral intelligence.
- Closed an oversubscribed $7 million Series A-2 in October 2025.
- Opened pre-release access to the CortX spectral foundation model with mass-spectrometry identification in 2026.

## Latest updates

- **2026-07** — Published a feature on AI-driven spectral intelligence for clinical diagnostics and pharmaceutical processing in BioPhotonics.
- **2026-01** — Received Frost & Sullivan's 2025 Technology Innovation Leadership recognition.
- **2026-01** — Joined the fifth MassRobotics Healthcare Robotics Startup Catalyst cohort.
- **2025-12** — Appointed former Neogen Chief Science Officer Rob Donofrio as Chief Life Science Officer.
- **2025-10** — Raised a $7 million Series A-2 co-led by RRE Ventures and Kibo Ventures; former Coherent CEO Chuck Mattera became chairman.
- **2025-08** — SpecAI was named a 2025 R&D 100 finalist.
- **2025-02** — Announced the Stanford and Case Western collaboration to develop TB QuickDetect.

## Links

- Website: https://www.hyperspectral.ai/
- LinkedIn: https://www.linkedin.com/company/hyper-spectral/

---

Profile page: https://yespress.io/hyperspectral
Published by YesPress — https://yespress.io
Last updated: 2026-08-22